Rotavirus serotype G9 is associated with more-severe disease in Latin America.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16804845.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.
Medical subject headings
- Rotavirus
- Rotavirus Infections